Senate Subcommittee Hearing on National Park Legislation
January 1, 2019
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing served as the formal legislative review process for over 20 separate bills that could impact federal land management, park boundaries, and heritage site designations across the United States.
Potentially affected actors named in the source documents. Mention is not a position.
National Park Service
The agency provides testimony and guidance on how proposed legislation would impact park operations and management.
Local Municipalities (e.g., City of Santa Clarita)
Local governments submitted letters for the record regarding how specific bills impact land within their jurisdictions.
Last recorded activity January 1, 2019.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on August 15, 2018, by the Subcommittee on National Parks.
- The committee reviewed 24 distinct legislative items, including various Senate bills (S.) and House resolutions (H.R./H. Con. Res.).
- P. Daniel Smith, Deputy Director of the National Park Service, provided testimony on behalf of the Department of the Interior.
- The record includes formal statements and letters from numerous external stakeholders, including the American Battlefield Trust, the Chesapeake Conservancy, and various city governments.
- The hearing record serves as the official repository for testimony and supplemental materials regarding the listed legislation.
Why It Matters
The hearing served as the formal legislative review process for over 20 separate bills that could impact federal land management, park boundaries, and heritage site designations across the United States.
Frequently Asked Questions
What was the purpose of this hearing?
Who testified at this hearing?
News Coverage
Lobbying Activity
340B Health
2026
“The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate "Gang of Six" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.”
SLOAT HIGGINS JENSENAND ASSOCIATES
on behalf of AMERICAN INTERNATIONAL GROUP
ROSE & KINDEL
on behalf of GLOBAL PHOTON SYSTEMS INC. & ITS SUBSIDIARIES
LAWRENCE J SUFFREDIN
on behalf of AMAZON
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of NEW YORK PRIVATE RESIDENCES CONDOMINIUM ASSOCIATION
PAT DOERR
on behalf of HOSPITALITY BUSINESS ASSOC OF CHICAGO
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
JEFFREY A GLASS
on behalf of CITIZENS UTILITY BOARD
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Legislative Bundling
The committee reviewed a high volume of disparate bills in a single hearing session, indicating a batch-processing approach to minor or non-controversial public land legislation.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools